Barry H. Trachtenberg Leads Issue on Cardio-Oncology. Methodist DeBakey Cardiovasc J. 2019;15(4):240.
The editors of the Methodist DeBakey Cardiovascular Journal are grateful to Barry H. Trachtenberg, MD, for his expert guidance in putting together this special issue on cardio-oncology.
Dr. Trachtenberg is a cardiologist specializing in cardio-oncology, heart failure, and cardiac transplantation at Houston Methodist Hospital and assistant professor of cardiology at Weill Cornell Medical College. He is the founder and director of the cardio-oncology program at Houston Methodist, where he works closely with and is a member of the Houston Methodist Cancer Center. Dr. Trachtenberg leads a team of cardiovascular experts who use cutting-edge methods to prevent and manage cardiovascular complications of cancer therapies, including chemo/immunotherapies and radiation. He also directs the cardiac amyloidosis program and oversees the multidisciplinary amyloid working group.
In addition, he is associate director of the mechanical circulatory support program at the Methodist DeBakey Cardiology Associates. As program director for the Advanced Heart Failure Fellowship at Houston Methodist Hospital, Dr. Trachtenberg enjoys training the next generation of cardiologists to manage complex heart failure cases. Dr. Trachtenberg is board certified in internal medicine, cardiovascular disease, echocardiography, and advanced heart failure and transplantation.
After earning his Bachelor of Science degree from the University of Pennsylvania, Dr. Trachtenberg attended medical school at the University of Texas-San Antonio. Next, he returned to his hometown of Houston for an internal medicine residency at Baylor College of Medicine. He then completed a fellowship in cardiology and advanced heart failure at the University of Miami Miller School of Medicine in Florida.
Outside of his clinical duties, Dr. Trachtenberg has published numerous papers on topics related to advanced heart failure, inflammatory cardiomyopathies, ventricular assist devices, and cardio-oncology and contributed to dozens of clinical trials. He is also a member of the American Heart Association, the International Society for Heart and Lung Transplantation, the Heart Failure Society of America, and the International CardiOncology Society of North America. He is the heart failure chair for the Texas chapter of the American College of Cardiology.